Product Information
PRAMIPEXOLE ER 2.25 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $1.4634 per EA under NDC 62332015730. Its NADAC has been published 185 times since Mar 22, 2023.
FDA first approved this application on Jan 2, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.25 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332015730
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PRAMIPEXOLE DIHYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204518FDA Approved
1/2/2019
TE Code
AB
On Market Since
1/3/2019
Pharmacological Classes
Price Statistics
The NADAC for PRAMIPEXOLE ER 2.25 MG TABLET has been published 185 times since Mar 22, 2023, and over the history we have for it it has declined 75.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4634 per EA |
|---|---|
| All-time high | $6.0474 (Apr 10, 2024) |
| All-time low | $1.3487 (Aug 19, 2026) |
| 52-week high | $2.3554 |
| 52-week low | $1.3487 |
| Median price | $3.4396 |
| Average price | $3.7732 |
| Largest weekly change | -26.7% (Apr 17, 2024) |
| Weeks tracked | 185 |
| Tracking since | Mar 22, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Pramipexole Dihydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonergot Dopamine Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PRAMIPEXOLE ER 2.25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PRAMIPEXOLE ER 2.25 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $1.4634 per EA (NDC 62332015730), effective Sep 30, 2026.
How has the price of PRAMIPEXOLE ER 2.25 MG TABLET changed over time?
Over the history we have for it, the NADAC for PRAMIPEXOLE ER 2.25 MG TABLET has declined 75.8%. It has been tracked across 185 weekly CMS publications since Mar 22, 2023.
What are the highest and lowest recorded NADAC prices for PRAMIPEXOLE ER 2.25 MG TABLET?
Since Mar 22, 2023, the NADAC for PRAMIPEXOLE ER 2.25 MG TABLET has ranged from a low of $1.3487 (Aug 19, 2026) to a high of $6.0474 (Apr 10, 2024), with a median of $3.4396 per EA.
Are there cheaper alternatives to PRAMIPEXOLE ER 2.25 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PRAMIPEXOLE ER 2.25 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PRAMIPEXOLE ER 2.25 MG TABLET?
PRAMIPEXOLE ER 2.25 MG TABLET (NDC 62332015730) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.